Congenital CMV: Difference between revisions
From IDWiki
Content deleted Content added
m Aidan moved page Special Congenital Congenital CMV to Congenital CMV without leaving a redirect |
No edit summary |
||
| Line 1: | Line 1: | ||
= Congenital CMV = |
|||
== Epidemiology == |
== Epidemiology == |
||
| Line 37: | Line 35: | ||
* Monitor CBC while on therapy |
* Monitor CBC while on therapy |
||
n c |
|||
[[Category:Pediatrics]] |
|||
Revision as of 01:35, 16 August 2019
Epidemiology
- Risk of transmission to fetus
- Primary infection: 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
- Non-primary
- Reinfection: 5% risk
- Reactivation: 1% risk
Clinical Presentation
- At birth
- Microcephaly
- Periventricular calcifications
- Chorioretinitis
- Sensorineural hearing loss
- Optic nerve atrophy
- Hepatosplenomegaly
- Cytopenia
- Later
- Cognitive deficits (7%)
- Sensorineural hearing loss (20%)
Diagnosis
- In mom, IgM antibodies
- In baby, urine PCR within 2 weeks of birth
Management
- Treatment is indicated for symptomatic babies
- Brain
- Hearing
- Eye
- IV ganciclovir or PO valganciclovir, for 6 months
- Monitor CBC while on therapy
